TY  - GEN
AU  - Folprecht,Gunnar
AU  - Gruenberger,Thomas
AU  - Bechstein,Wolf O
AU  - Raab,Hans-Rudolf
AU  - Lordick,Florian
AU  - Hartmann,Jörg T
AU  - Lang,Hauke
AU  - Frilling,Andrea
AU  - Stoehlmacher,Jan
AU  - Weitz,Jürgen
AU  - Konopke,Ralf
AU  - Stroszczynski,Christian
AU  - Liersch,Torsten
AU  - Ockert,Detlev
AU  - Herrmann,Thomas
AU  - Goekkurt,Eray
AU  - Parisi,Fabio
AU  - Köhne,Claus-Henning
TI  - Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial
SN  - 1474-5488
PY  - 2010///0308
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Agents
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Austria
KW  - Camptothecin
KW  - Cetuximab
KW  - Chemotherapy, Adjuvant
KW  - Colorectal Neoplasms
KW  - pathology
KW  - ErbB Receptors
KW  - analysis
KW  - Female
KW  - Fluorouracil
KW  - Germany
KW  - Hepatectomy
KW  - Humans
KW  - Leucovorin
KW  - Linear Models
KW  - Liver Neoplasms
KW  - chemistry
KW  - Magnetic Resonance Imaging
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - Neoadjuvant Therapy
KW  - Odds Ratio
KW  - Organoplatinum Compounds
KW  - Proto-Oncogene Proteins
KW  - genetics
KW  - Proto-Oncogene Proteins B-raf
KW  - Proto-Oncogene Proteins p21(ras)
KW  - Retrospective Studies
KW  - Risk Assessment
KW  - Time Factors
KW  - Tomography, Spiral Computed
KW  - Treatment Outcome
KW  - ras Proteins
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1016/S1470-2045(09)70330-4
ER  -